Skip to main content

Animations

MJFF Publications

3781 - 3790 of 6431 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00172-z
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Il-10 signaling reduces survival in mouse models of synucleinopathy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00169-8
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Core Alzheimer’s disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-021-00812-9
    Citation Count: 2
  • Summary Details
    OPEN
    Title: In situ architecture of neuronal α-Synuclein inclusions
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-22108-0
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02285-4
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13168
    Citation Count: 24
  • Summary Details
    OPEN
    Title: High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2021.100463
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Computational medication regimen for Parkinson’s disease using reinforcement learning
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-88619-4
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALS
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2021.642324
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Genetic control of the human brain proteome
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.01.012
    Citation Count: 86
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.